Resistance to chemotherapy: What are the risks for the reindeer industry?

  • P. J. Waller CSIRO Division of Animal Health, McMaster Laboratory, Private Bag No. 1, Glebe, NSW 2037, Australia. Present Address: The Royal Veterinary and Agricultural University, Institute of Microbiology and Hygiene, 13, Bulowsvej, DK-1870 Frederiksberg C. Phone: 3
DOI: https://doi.org/10.7557/2.10.4.905
Keywords: reindeer, chemotherapy, drug resistance, anthelmintics,

Abstract

Although no drug resistance has been reported so far for parasites of reindeer, it would be unwise to assume that this situation will remain the same indefinitely. It is important to consider the principles of selection for resistance and plan ways of limiting these so that the emergence of resistance can be avoided.
Published
1990-09-01
How to Cite
Waller, P. J. (1990). Resistance to chemotherapy: What are the risks for the reindeer industry?. Rangifer, 10(4), 14-18. https://doi.org/10.7557/2.10.4.905
Issue
Vol 10 (1990): Special Issue No. 4
Section
Articles
Copyright (c) 2015 P. J. Waller

Authors retain copyright and grant Rangifer irrevocable and non-exclusive right of publication with the work simultaneously licensed under a Creative Commons Attribution License (CC-BY). This means, among other things, that anyone is free to copy and distribute the content, as long as they give proper credit to the author(s) and the journal. For further information, see Creative Commons website for human readable or lawyer readable versions.